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Purpose: Hypoxia preconditioning protects corneal stromal cells from stress-induced death. This study determined
whether the transcription factor HIF-1α (Hypoxia Inducible Factor) is responsible and whether this is promulgated by
VEGF (Vascular Endothelial Growth Factor).
Methods: Cultured bovine stromal cells were preconditioned with hypoxia in the presence of cadmium chloride, a
chemical inhibitor of HIF-1α, and HIF-1α siRNA to test if HIF-1α activity is needed for hypoxia preconditioning protection
from UV-irradiation induced cell death. TUNEL assay was used to detect cell apoptosis after UV-irradiation. RT-PCR
and western blot were used to detect the presence of HIF-1α and VEGF in transcriptional and translational levels.
Results: During hypoxia (0.5% O2), 5 μM cadmium chloride completely inhibited HIF-1α expression and reversed the
protection by hypoxia preconditioning.  HIF-1α siRNA (15 nM) reduced HIF-1α expression by 90% and produced a
complete loss of protection provided by hypoxia preconditioning.  Since VEGF is induced by hypoxia, can be HIF-1α
dependent, and is often protective, we examined the changes in transcription of VEGF and its receptors after 4 h of hypoxia
preconditioning.  VEGF and its receptors Flt-1 and Flk-1 are up-regulated after hypoxia preconditioning.  However, the
transcription and translation of VEGF were paradoxically increased by siHIF-1α, suggesting that VEGF expression in
stromal cells is not down-stream of HIF-1α.
Conclusions: These findings demonstrate that hypoxia preconditioning protection in corneal stromal cells requires
HIF-1α, but that VEGF is not a component of the protection.
Keratocyte apoptosis is the earliest stromal event noted
after corneal epithelial injury and has an important role in the
overall wound healing response [1]. Keratocyte loss promotes
the activation and proliferation of surrounding keratocytes
which  leads  to  a  change  in  gene  expression  and  matrix
production that can affect cornea clarity [2-5]. Preventing
keratocyte loss has been suggested as a possible approach to
reduce  keratocyte  activation  and  possible  subsequent
myofibroblast formation [6]. Hypoxia preconditioning has
been shown to be protective in brain [7], bladder [8], and retina
[9]. We have shown that hypoxia preconditioning provides
generalized protection to corneal stromal cells against induced
apoptosis in vitro and in an ex vivo cornea model. Cobalt
chloride, which is a chemical inducer of HIF-1α, provided
protection to corneal stromal cells in the absence of hypoxia
[10].  The  nuclear  transcription  factor  HIF-1α  (hypoxia
inducible factor) is induced by hypoxia in these cells and
protection is also provided by an HIF-1α inducer, Cobalt
chloride  (CoCl2),  suggesting  that  HIF-1α  is  a  necessary
component of hypoxia preconditioning protection [10].
HIF-1α is the major transcription factor that controls the
expression  of  hypoxia-regulated  genes.  To  activate
transcription of target genes, HIF-1α dimerizes with ARNT
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(aryl hydrocarbon receptor nuclear translocator) and binds to
the  HRE  (hypoxia  responsive  element  ).  ARNT  is
constitutively  expressed  so  the  hypoxic  induction  and
modification  of  HIF-1α  determines  the  transcriptional
activity. Under normoxic conditions, HIF-1α is continuously
degraded in proteasomes. Oxygen-dependent hydroxylation
of proline residues in the ODD domain of HIF-1α leads to
interaction with the VHL (von Hippel Lindau) ubiquitin ligase
complex. Furthermore, oxygen-dependent hydroxylation of
asparagine  in  the  CAD  domain  prevents  interaction  of
HIF-1α  with  the  p300/CBP  coactivator  that  is  needed  to
induce transcription [11]. HIF-1α levels are inversely related
to oxygen tension with a half-maximal response at 1.5-2%
O2 and a maximal response at 0.5% O2 [12]. HIF-1α has been
shown  to  be  pro-apoptotic  and  anti-apoptotic.  Hypoxia
increases the expression of Nips, a pro-apoptotic member of
the  Bcl-1  family  in  human  tumor  cells  [13].  Hypoxia
preconditioning  can  be  anti-apoptotic  either  by  HIF-1α
dependent  or  independent  pathways.  For  example,  up-
regulation of the anti-apoptotic protein IAP-2 by hypoxia does
not require HIF-1α and is regulated by the NFκb pathway
[14].  However,  protection  of  cortical  neurons  [15,16],
pancreatic cancer cells [16], and retinal photoreceptors require
HIF-1α, which is generally associated with upregulation of
protective growth factors such as VEGF (vascular endothelial
growth factor) and EPO (erythropoietin).
The VEGF gene has HREs and is a well-known target
gene regulated by HIF-1α. VEGF expression can be increased
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1020by hypoxia preconditioning [17] or over-expression of HIF
[18]. VEGF has been shown to prevent vascular endothelial
cell death down stream of HIF-1α by at least two previous
studies [19,20]. VEGF, down-stream of HIF-1α, also protects
cardiomyocytes following ischemia [21]. VEGF and other
tyrosine kinase activated receptors activate PI-3K and akt
(Protein Kinase B) leading to phosphorylation of apoptotic
factors that ultimately suppress release of cytochrome C and
activation  of  caspases  [22].  A  recent  study  however,  has
shown that VEGF expression can be HIF-1α independent as
shown in skeletal muscle cells where VEGF is regulated by
PGC-1α ( peroxisome proliferator activated receptor gamma
coactivator-1 alpha ) [23].
In  this  study,  we  found  that  siRNA  knockdown  of
HIF-1α abrogated hypoxia dependent protection of corneal
stromal cells. Because VEGF production is increased during
corneal  hypoxia  and  VEGF  has  very  strong  protective
functions in many systems, we examined VEGF expression
during HIF-1α knockdown. We found that VEGF expression
was actually increased indicating that it is not a component of
hypoxia dependent cell protection.
METHODS
Cell  culture:  Corneal  stromal  cells  were  cultured  as
previously described [10]. Briefly, blocks of stroma were cut
from fresh bovine cornea and cultured in DMEM (GIBCO)
supplemented with 10% fetal bovine serum (FBS), 100 units/
ml of penicillin, 100 μg/ml of streptomycin, and 0.25 μg/ml
of amphotericin B. Corneal stromal fibroblasts migrated from
the  stromal  explants  and  grew  exponentially  at  densities
below 5×105 cells/ml. Second to third generation fibroblasts
were seeded onto coverslips or petri-dishes and used in all cell
culture experiments.
Induction of hypoxia: For hypoxia preconditioning, cells were
placed in a hypoxia chamber (Coy Lab Products Inc., Grass
Lake,  MI)  equilibrated  with  5%  CO2  and  0.5%  oxygen-
balance nitrogen for 4 h duration as indicated.
UV-irradiation: Corneal fibroblasts (5×104 cells) were sub-
cultured to 25 mm coverslips in DMEM supplemented with
0.5% FBS for 2 days. Media was changed immediately before
each experiment. This amount of serum was sufficient to
prevent  cell  death,  but  does  not  promote  proliferation.  A
germicidal  lamp  (TUV/30W/G30  T8;  Philips  Lighting
Company, Somerset, NJ) that emitted radiation ranging from
230 to 400 nm was used as the UV source as previously
described  [10]  Cells  were  irradiated  for  2  min,  which
corresponds to 5.1 mJ/cm2. Cells were irradiated at 80-90%
confluence. Culture media was removed and replaced with
2 ml of a balanced ringer’s solution to avoid variations in UV
absorption  from  media  components.  After  irradiation  the
ringer’s solution was discarded and replaced by fresh DMEM/
0.5% FBS.
TUNEL  assay  and  cell  counting:  Four  hours  after  UV-
irradiation,  cells  on  coverslips  were  fixed  in  4%
formaldehyde/PBS at 4 °C for 25 min. Following fixation the
cells were rinsed twice with PBS and permeabilized with
prechilled  0.2%  Triton  X-100/PBS  on  ice  for  5  min.  A
fluorescence-based TUNEL assay was used according to the
manufacturer's instructions (ApoAlert; BD Biosciences, Palo
Alto, CA). Cells were counterstained with DAPI and mounted
with prolong antifade reagent (Molecular Probes, Eugene,
OR). Images were obtained with a fluorescence microscope
(Nikon E600; Nikon, Melville, NY) equipped with a charge
coupled  device  camera  with  active  cooling  system.  For
fibroblasts cultured on coverslips, five random distinct 200X
microscopic  fields  were  photographed  on  each  coverslip.
DAPI(+) cells were counted to obtain the total cell count.
DAPI(+) and TUNEL(+) cells were counted as apoptotic cells.
DAPI(−) and TUNEL(+) areas were considered artifacts and
excluded from the count. Data was collected from about 750
cells for each condition in each experiment. Experiments were
repeated at least three times giving a total of at least 2,000
cells counted per condition.
RNA interference and cell transfection: Corneal fibroblasts
(2×105  cells)  were  sub-cultured  to  60  mm  petri-dishes  or
5×104 cells were sub-cultured to 25 mm coverslips in DMEM
supplemented  with  0.5%  FBS  for  one  day  to  reach  50%
confluence. RNAi targeting HIF-1α was designed using Bos
Taurus HIF-1α mRNA (GenBank NM_174339). The position
for siRNA targeting starts at 1,450 of the HIF-1α mRNA. The
sense 5’-AAG AAG GAG CCT GAT GCT TTA CCT GTC
TC-3’ and antisense sequence 5’-AAT AAA GCA TCA GGC
TCC TTC CCT GTC TC-3’, were synthesized and annealed
as  following  the  manufacturer’s  protocol  (Cat  No.  1620;
Ambion Inc., Austin, TX). Cells were transfected with the
oligonucleotide duplexes for 6 h and then changed to regular
medium.  For  mock  transfection,  cells  were  exposed  to
oligofectamine  alone.  A  siRNA  targeted  to  an  irrelevant
mRNA (Dharmacon Research, Chicago, IL) serves as non-
targeting control.
RT-PCR:  Total  RNA  was  isolated  using  TRIzol  reagent
(Invitrogen).  cDNA  synthesis  was  performed  using
Invitrogen Superscript III (200 U μl−1), Oligo dT12–18 primer
and  1  μg  mRNA  as  manufacture’s  instructions.  VEGF,
FLK-1, and Flt-1 primers were selected to amplify the 508 bp,
386  bp,  and  334  bp  fragments  of  mRNA  respectively
according to previous report [24]. Primer sequences: VEGF
sense 5-TAC CTT CAC CAT GCA AG, VEGF antisense 5-
CAC ATC TGC AAG TAC GTT CG; FLK-1 sense 5’-TTC
TTG CCC AAC AAT CAG AG, FLK-1 antisense 5’-TAG
CTG GGA ATA CTG AAG CC; Flt-1 sense 5’-TAT AGC
ACC AAG AGC GAC, Flt-1 antisense 5’-GTG TCG AGT
ACG  TAA  ACG.  Each  25  ul  of  amplification  reaction
contains  0.4  μl  Taq  polymerase  (cat.  92877933;  Roche,
Nutley, NJ), 2 μl of dNTP mix, 0.3 μm primers, 6 μl of cDNA
for Flt-1 and 2 μl of cDNA for everything else. The PCR
parameters are 40 cycles as follow: denaturation at 94 °C for
15 s, annealing at 55–60 °C for 25 s, extension at 72 °C for 35
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1021s, according to a previous report [24]. The PCR products were
separated on 1.7% agarose electrophoresis gels and stained
with 0.5 μg/ml ethidium bromide and recorded for analysis.
Western blot analysis: Whole cell lysates were prepared as
previously described [25]. Briefly, treated and untreated cells
were extracted with lysis buffer (50 mmol/l Tris–HCl, pH 7.5,
5  mmol/l  EDTA,  150  mmol/l  NaCl,  0.5%  Triton  X-100,
10 mmol/l sodium fluoride, 20 mmol/l β-mercaptoethanol,
250  μmol/l  sodium  orthovanadate,  1  mmol/l  PMSF,  and
complete protease inhibitor cocktail; Sigma, St Louis, MO),
and incubated at 4 °C for 30 min. The lysates were sonicated
and centrifuged at 14,000x g for 15 min. The supernatants
were collected and stored at −80 °C. Protein concentrations
were determined by the BCA method. Protein (50 μg) was
separated  on  8-12%  polyacrylamide-SDS  gel  and
electroblotted  onto  nitrocellulose  membranes  (Bio-Rad
laboratories,  Hercules,  CA).  After  blocking  with  TBS/5%
skim milk, the membrane was incubated overnight at 4 °C
with  primary  antibodies  against  HIF-1α  (Cat:  MA1-516;
ABR, Rockford, IL) at concentration of 1:2,000 or polyclonal
antibody  against  VEGF  (Cat:  sc-507;  Santa  Cruz
Biotechnology, Inc., Santa Cruz, CA) , at 1:200 followed by
peroxidase conjugated anti-mouse IgG or anti-rabbit IgG for
1 hr at room temperature. Signals were detected with ECL.
Data was analyzed using Un-scan-it gel analysis software
(Silk  Scientific,  Orem,  UT).  Relative  increase  in  protein
expression compared to its own control is calculated.
Statistical analysis: Data is presented as the mean±SE for at
least  three  separate  experiments.  Student's  t-test  was
employed for statistical analysis, with significant differences
determined as p<0.05.
RESULTS
Cadmium chloride prevents induction of HIF-1α and inhibits
hypoxia preconditioning protection: Previously, we showed
that 4 h of hypoxia preconditioning or application of CoCl2, a
chemical HIF-1α inducer, provided protection against UV
induced corneal stromal cell apoptosis [10], suggesting that
HIF-1α  has  a  role  in  preventing  apoptosis.  Conversely,
treatment with low concentrations of cadmium chloride have
been shown to inhibit the activation of HIF-1α by hypoxia
[26-28].  Here  we  test  whether  cadmium  chloride  (5  μM)
reduces HIF-1α activation by hypoxia in corneal stromal cells
and whether it abrogates hypoxia preconditioning protection.
Figure 1A shows that cadmium chloride significantly
reduces the induction of HIF-1α by hypoxia. Figure 1B shows
that  hypoxia  preconditioning  significantly  protected  cells
from  UV  irradiation.  However,  the  addition  of  cadmium
eliminated this protection. Cadmium alone had no significant
effect on HIF-1α (figure 1A) or apoptosis (data not shown).
These  results  show  that  decreased  HIF-1α  levels  lead  to
reduction  of  protection,  which  suggests  that  HIF-1α  is
involved in the hypoxia protection.
Characterization of RNAi targeting bovine HIF-1α in bovine
corneal stromal cells: We designed a bovine specific HIF-1α
Figure 1. Effect of Cadmium on HIF-1α
accumulation  and  hypoxia
preconditioning  protection.  A:  Cells
were  incubated  under  normoxia  with
200 μM CoCl2 (as a positive control), 5
μM  CdCl2  alone,  hypoxia  (0.5%  O2)
alone, or hypoxia with CdCl2 for 4 h.
Whole  cell  lysates  were  collected
immediately after treatment, separated
on  SDS-PAGE  gel  and  blotted  for
HIF-1α.  β-actin  was  detected  as  a
loading control. B: Cells were pretreated
with hypoxia with or without CdCl2 for
4 h and irradiated 2 min with UV. Four
hours after irradiation, cells were fixed
and  stained  for  TUNEL.  Bar  graph
shows percentage of TUNEL positive
cells  in  indicated  groups.  Error  bars
represent  standard  error  of  the  mean
(n=3);  the  asterisk  indicates
significantly different from UV control
(p<0.05).
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1022small interference RNA. The efficiency and potency of this
siRNA was tested in corneal stromal cells. Figure 2 shows that
the HIF-1α siRNA produced a significant reduction in the
hypoxia induced HIF-1α expression. The maximum effect
(about 90% of reduction) of the siRNA could be achieved a
concentration as low as 15 nM. Non targeting siRNA control
did not significantly affect the HIF-1α level.
Complete  loss  of  hypoxia  preconditioning  protection  by
siHIF-1α: To definitively determine that HIF-1α is involved
in hypoxia protection, we tested the effect of HIF-1α siRNA
on  hypoxia  protection  against  UV-irradiation  induced
apoptosis in corneal stromal cells. Figure 3 shows that UV
irradiation induced a 40±8.5% apoptotic rate whereas hypoxia
preconditioning reduces this apoptotic rate to 20±3.0%. This
is a similar protective effect to that reported previously [10].
Fifteen and 25nM siRNA targeting HIF-1α eliminates the
hypoxia preconditioning protection, bringing the apoptotic
rate back to 37.5±5.5% and 42±10.1%, respectively. These
results demonstrate that hypoxia protection requires HIF-1α
expression.
VEGF  is  induced  by  hypoxia  preconditioning  in  bovine
corneal stromal cells: Genes prominently induced by hypoxia
include growth factors like VEGF and EPO [29,30]. Among
these growth factors, VEGF was found to be up-regulated in
most cell types [31]. We tested here whether the transcription
of VEGF and its receptors Flk-1 and Flt-1 are up-regulated in
corneal stromal cells by hypoxia preconditioning. Figure 4
shows that VEGF is prominently up-regulated by hypoxia and
both VEGF receptors Flk-1 and Flt-1 are also up-regulated.
The transcription of receptor Flt-1 is significantly lower than
Flk-1 in corneal stromal cells.
Induction of VEGF by hypoxia preconditioning is not reduced
by  siHIF-1α:  VEGF  has  been  shown  to  be  directly  up-
regulated by HIF-1α in vascular endothelial cells and kidney
[32,33]. But recent evidence in skeletal muscle showed that
VEGF expression is completely independent of HIF-1α [23].
We tested whether VEGF is down stream of HIF-1α in bovine
corneal stromal cells. Figure 5A shows that VEGF mRNA is
increased after hypoxia treatment but it is not reduced by
HIF-1α  siRNA.  Figure  5B  shows  that  HIF-1α  siRNA
significantly reduces the HIF-1α level, but it does not reduce
VEGF expression. On the contrary, VEGF expression under
hypoxia treatment with HIF-1α siRNA increases 3.3±0.1 fold
compared to control which is significantly higher compared
to hypoxia alone (2.1±0.3 fold increase).
DISCUSSION
The concept of hypoxia preconditioning protection is well
documented  in  many  tissues  and  various  factors  are
Figure 2. Effect of HIF-1α siRNA on
HIF-1α protein expression. Cells were
transfected with 15 and 25 nM HIF-1α
siRNA  and  an  siRNA  non  targeting
control as indicated for 6 h. Twenty-four
hours  after  transfection,  cells  were
exposed to 4 h of hypoxia. Protein was
collected  immediately  after  treatment
and  blotted  for  HIF-1α.  Bar  graph
represents the band intensity relative to
the  control.  Error  bars  represent  the
standard error of the mean (n=3). β-actin
is detected as loading control.
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1023demonstrated to participate in the protection [9,34-37]. The
production  of  EPO  during  whole  body  hypoxia  protected
photoreceptors from light induced cell death [9]. Hypoxia is
also  known  to  stimulate  translocation  of  hsp27  and  αB-
crystallin from diffuse locations to defined structures, which
is associated with a decrease in caspase-3 activity [38,39].
HIF-1α is a major modulator in the hypoxic environment. It
is generally considered to play a protective role and induces
the up-regulation of other protective factors like Hsp27 [40]
and VEGF [32].
VEGF has been shown to be protective in several cell
types such as skeletal muscle and kidney cells [23,32]. But
whether the effect of VEGF on protection is dependent on
HIF-1α is cell type specific. In this study, we used cadmium
chloride to reduce the induction of HIF-1α. Cadmium chloride
5 μM, in the presence of hypoxia, completely blocks HIF-1α
induction by hypoxia (Figure 1A). UV induced apoptosis of
cells preconditioned by hypoxia in the presence of cadmium
was not significantly different from UV alone, suggesting that
prevention of HIF-1α induction is necessary for protection.
The HIF-1α specific siRNA efficiently reduces HIF-1α
expression by 90% at 15 nM (Figure 2B). This reduction in
HIF-1α  completely  eliminates  the  protection  provided  by
hypoxia preconditioning (Figure 3) indicating that HIF-1α is
essential for this protection. A similar conclusion has been
Figure 3. Effect of HIF-1α siRNA on
hypoxia  preconditioning  protection.
Bovine stromal cells were transfected
with the 15 nM (hypo15uv) and 25 nM
(hypo25uv)  HIF-1α  siRNA  and  non
targeting  siRNA  control  (labeled  as
hyposiCuv) for 6 h. Twenty-four hours
later, cells were exposed to hypoxia for
4  h  and  then  stressed  with  UV-
irradiation for 2 min. Cells were stained
with TUNEL 4 h after irradiation. Error
bars represent the standard error of the
mean  (n=3).  The  asterisk  indicates
statistically different from control UV
irradiation.
Figure 4. Up-regulation of VEGF and its
receptors  by  hypoxia  in  bovine
keratocytes. Bovine stromal cells were
treated with hypoxia for 4 h. Total RNA
was  collected  immediately  after
treatment.  Image  shows  RT-PCR
analysis for VEGF, FLK-1, and Flt-1.
GAPDH  was  detected  as  an  internal
control. Representative image of three
experiments is shown.
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1024drawn from a mouse study where complete loss of hypoxia
protection was due to partial deficiency of HIF-1α [41].
The regulation of VEGF in response to hypoxia can be
mediated by HIF-1α in a number of tissues [32,42]. Our result
indicates that VEGF expression is up-regulated by hypoxia
(figure 4), but that this increase in VEGF transcription and
expression is independent of HIF-1α (figure 5). Therefore,
protection by hypoxia depends on HIF-1α, but not VEGF in
corneal stromal cells. A recent study on rat heart also showed
that HIF-1α is protective, but is not VEGF or EPO dependent
[43]. The regulation of VEGF expression must be cell type
specific since in kidney [32] and vascular endothelial cells
[33] VEGF, which is protective, is dependent on HIF-1α. On
the other hand, VEGF expression is totally HIF independent
in  skeletal  muscle  cells  where  VEGF  is  regulated  by
peroxisome  proliferator  activated  receptor  gamma
coactivator-1  alpha  (PGC-1α)  [23].  Interestingly,  a  recent
study  has  shown  that  VEGF  expression  is  regulated  by
HIF-2α in human lung endothelial cells [44]. Further studies
are needed to determine the mechanism for VEGF regulation
in corneal stromal cells.
Overall, the results from this study show that hypoxia
preconditioning protection requires induction of HIF-1α. A
likely protective factor, VEGF, is up-regulated by hypoxia
preconditioning, but is not induced by HIF-1α, indicating that
VEGF  is  not  the  protective  factor  during  hypoxia
preconditioning. We have preliminary evidence to suggest
that the PI-3K and akt pathways are activated by hypoxia. This
suggests that Receptor Tyrosine Kinase ligands other than
VEGF,  (e.g.,  EPO)  are  required  for  protection  in  corneal
stromal cells. Further studies are needed to determine these
factors induced by HIF-1α that may protect corneal stromal
cells during hypoxia preconditioning.
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